Archive - February 2025
STAT+: Eli Lilly to lower price of Zepbound vials, offer more doses
Warning Letters: An Untapped Source for Understanding When Device Changes Require a New 510(k)
Censored Science Can’t Save Lives
STAT+: Pharmalittle: We’re reading about Zepbound price and dose changes, compounders suing FDA, and more
Working Together to Improve the Environment
Una misión para curar a los ‘monstruos’ que nos dieron el Ozempic
Wins for bulk milk testing and deafness research
Supplying Sustainably